BMC Medical Ethics is a leading open-access journal dedicated to the critical exploration and dissemination of knowledge surrounding ethical issues in healthcare and medicine. Published by BMC, and headquartered in the United Kingdom, this journal has become a cornerstone in the field since its inception in 2000, with a remarkable focus on health policy, nursing ethics, and the complex legal aspects intertwining with healthcare practices. With an impressive Q1 ranking across multiple categories, including Health Policy and Health (Social Science), it ranks among the top journals globally—particularly notable with its Scopus rankings reflecting a strong 85th percentile in Nursing and an 81st percentile in Social Sciences. As an open-access publication, BMC Medical Ethics ensures that research findings are readily accessible, fostering a collaborative environment for researchers, practitioners, and students alike. The journal's commitment to ethical discourse not only advances academic inquiry but also shapes the practices and policies that govern healthcare delivery; thus, making it an invaluable resource for those engaged in the advancement of medical ethics.

Monash Bioethics Review, published by SPRINGER HEIDELBERG, is a leading journal in the interdisciplinary realm of bioethics, dedicated to exploring critical issues at the intersection of health policy, philosophy, and the social sciences. With an impressive impact factor placing it in Q1 in Philosophy and notable rankings across disciplines, including Q3 in Health Policy and Medicine, it serves as an essential platform for researchers, professionals, and students alike. This journal not only aims to foster robust discourse on ethical dilemmas but also seeks to contribute to policymaking through rigorous analysis and research. Covering articles from its inception in 1994 to the present, Monash Bioethics Review remains committed to addressing contemporary ethical challenges in medicine and society, making it a vital resource for those keen on navigating the complexities of bioethical thought.

Public Health Ethics is a key journal published by Oxford University Press, dedicated to the intersection of public health, ethics, and policy. With an ISSN of 1754-9973 and an E-ISSN of 1754-9981, this journal has been a vital resource since its inception in 2009 and continues to contribute to the discourse until 2024. As a Q3 journal, it holds ranks of #17/46 in 'Nursing - Issues, Ethics and Legal Aspects' and #146/310 in 'Medicine - Health Policy' according to Scopus, reflecting its significance within the research community. The journal aims to address urgent questions and ethical dilemmas faced in public health practice and policy, making it essential reading for researchers, professionals, and students interested in health policy, ethics, and legal implications impacting public health. The absence of open access underlines the journal’s commitment to maintaining high standards of peer-reviewed research, encouraging rigorous scholarship that fosters innovative solutions to pressing public health challenges.

BIOETHICS is a leading academic journal published by Wiley, dedicated to exploring the multifaceted issues at the intersection of healthcare, philosophy, and policy. With an ISSN of 0269-9702 and an E-ISSN of 1467-8519, it has established itself as a critical platform for scholarly discourse since its inception in 1987. The journal holds impressive rankings, featuring in the Q1 category in both Health (social science) and Philosophy, alongside a Q2 rating in Health Policy for 2023. This positions BIOETHICS in the top echelons of its fields, ranking 35th out of 806 in Philosophy and garnering high percentiles across relevant disciplines. By fostering a deeper understanding of ethical implications in medical and social contexts, BIOETHICS serves as an essential resource for researchers, professionals, and students committed to addressing contemporary challenges in health and policy. The journal is accessible through institutional subscriptions and offers an engaging platform for the dissemination of significant research findings and theoretical advancements, paving the way for future exploration in bioethical inquiry.

Developing World Bioethics, published by WILEY, is an esteemed journal dedicated to the exploration and advancement of ethical issues in health and healthcare within developing countries. Since its inception in 2001, this journal has become a critical platform for disseminating scholarly research and discourse that address complex bioethical challenges in varied socio-economic contexts. With an impressive Q2 ranking in multiple categories, including Health Policy and Issues, Ethics and Legal Aspects, it stands out as a vital resource among its peers, boasting significant Scopus rankings that highlight its influence and contribution to the fields of health and social sciences. The journal is committed to fostering interdisciplinary dialogue and insight, making it an invaluable asset for researchers, professionals, and students keen on bioethics and health policy. While the journal operates on a subscription basis, it provides broad access to its diverse range of articles, ensuring that cutting-edge bioethical perspectives are available to stakeholders worldwide, with a focus on innovative solutions and best practices in healthcare systems globally.

The International Journal of Chinese & Comparative Philosophy of Medicine, published by GLOBAL SCHOLARLY PUBLICATIONS, is a pivotal scholarly platform dedicated to advancing the discourse around traditional Chinese medicine and comparative philosophies in healthcare. With the ISSN 1386-6354, this journal provides a rich repository of peer-reviewed articles that explore integrative approaches to medicine, addressing both historical context and contemporary applications. Although specific metrics such as impact factor are currently unavailable, it aspires to foster interdisciplinary dialogue among researchers, professionals, and students by encouraging innovative thinking and comparative analysis within the realm of medical philosophy. While currently operating under non-open access guidelines, the journal remains committed to disseminating knowledge that bridges diverse medical practices, making it an invaluable resource for those engaged in the study and application of philosophical medicine.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

Christian Bioethics is a pivotal journal published by Oxford University Press, dedicated to the interdisciplinary exploration of bioethical issues from a Christian perspective. Since its inception in 1995, the journal has served as a crucial platform for scholars, practitioners, and students to engage with complex ethical questions at the intersection of medicine, philosophy, and religious studies. With an evolving scope that reflects contemporary debates in bioethics, the journal has achieved notable rankings, including Q2 in Religious Studies and Q3 in Philosophy in 2023, underscoring its significance in these fields. While not open access, Christian Bioethics continues to bridge gaps between faith and science, encouraging rigorous dialogue on how Christian ethics can inform bioethical decision-making and policy. It is essential reading for those looking to deepen their understanding of ethical issues shaped by religious convictions, making it an invaluable resource for researchers and professionals alike.

Medecine & Droit, an esteemed journal published by ELSEVIER MASSON, CORP OFF, serves as a vital resource for the intersection of law and medicine. Since its inception in 1995, this journal has facilitated scholarly discourse by publishing innovative research, case studies, and reviews that explore the complexities of legal frameworks impacting medical practice and public health. Although currently classified in the fourth quartile within both the Law and Medicine (miscellaneous) categories for 2023, its contributions are important for legal professionals and healthcare providers seeking to navigate the evolving landscape of medical laws. With an ISSN of 1246-7391 and E-ISSN 1873-6475, it provides essential insights and stimulates interdisciplinary collaboration within academia. Authors and researchers are encouraged to contribute and engage with critical topics shaping the future of medicine and law through this essential publication.

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.